Stockscreener 앱 받기
9.74
3.73%
0.35
시간 외 거래:
9.75
0.010
+0.10%
전일 마감가:
$9.39
열려 있는:
$9.53
하루 거래량:
482.52K
Relative Volume:
1.36
시가총액:
$311.42M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-2.9515
EPS:
-3.3
순현금흐름:
$-31.31M
1주 성능:
-2.21%
1개월 성능:
-13.65%
6개월 성능:
+28.67%
1년 성능:
+297.55%
1일 변동 폭
$9.2277
$9.8575
1주일 범위
$8.87
$10.11
52주 변동 폭
$2.4714
$12.88
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| DCTH | 9.74 | 311.42M | 2.07M | -47.68M | -31.31M | -3.30 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth (NASDAQ:DCTH) - Seeking Alpha
(DCTH) Investment Analysis - Stock Traders Daily
Delcath Systems Stock (NASDAQ:DCTH) Among the Best Multibagger Stock to Buy Heading into 2025 - Insider Monkey
Rosalind Advisors, Inc. Increases Stake in Delcath Systems Inc - GuruFocus.com
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Intrahepatic Cholangiocarcinoma Treatment Market size is expected to grow owing to the launch of emerging therapies by 2034, estimates DelveInsight - Barchart
FY2024 EPS Estimate for Delcath Systems Raised by Analyst - MarketBeat
FY2028 EPS Forecast for Delcath Systems Decreased by Analyst - MarketBeat
Uveal melanoma Treatment Market Countermeasures Of Economic - openPR
HC Wainwright Reiterates Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024, a 44% increase - Medical Buyer
Delcath Systems Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Delcath Systems stock soars to 52-week high of $12 amid robust gains - Investing.com Australia
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2024 Earnings Call Transcript - Insider Monkey
Delcath Systems Reports Strong Q3 Growth and Expansion - TipRanks
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN
Delcath Systems Inc (DCTH) Q3 2024 Earnings: Revenue Surpasses E - GuruFocus.com
Delcath Systems, Inc. (DCTH) Reports Q3 Loss - Yahoo Finance
Delcath Systems Revenue Surges 44% to $11.2M as HEPZATO Launch Gains Momentum | DCTH Stock News - StockTitan
Uncovering Potential: Delcath Systems's Earnings Preview - Benzinga
(DCTH) Investment Analysis and Advice - Stock Traders Daily
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Delcath Systems to Participate in Upcoming Investor Conferences - StockTitan
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 26% Share Price Bounce - Simply Wall St
Comparing Cell MedX (OTCMKTS:CMXC) & Delcath Systems (NASDAQ:DCTH) - Defense World
Delcath Systems (DCTH) to Release Quarterly Earnings on Friday - MarketBeat
Delcath Systems (DCTH) Scheduled to Post Quarterly Earnings on Friday - Defense World
(DCTH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
DCTHDelcath Systems Inc Latest Stock News & Market Updates - StockTitan
Delcath Systems to Host Third Quarter 2024 Earnings Call - StockTitan
Delcath Systems (NASDAQ:DCTH) Upgraded to "Hold" at StockNews.com - MarketBeat
Delcath Systems Inc (DCTH) Trading 3.48% Higher on Oct 22 - GuruFocus.com
Delcath Systems (NASDAQ:DCTH) Rating Lowered to Sell at StockNews.com - Defense World
Delcath shares rise on record sales, analyst reiterates buy rating By Investing.com - Investing.com UK
Analyst Scoreboard: 4 Ratings For Delcath Systems - Benzinga
Delcath shares rise on strong 3Q sales, analyst reiterates buy - Investing.com
Delcath shares rise on strong 3Q sales, analyst reiterates buy By Investing.com - Investing.com South Africa
Delcath Systems' (DCTH) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024 - Medical Buyer
StockNews.com Lowers Delcath Systems (NASDAQ:DCTH) to Sell - MarketBeat
Delcath triggers $25 million financing with Q3 revenue - Investing.com
Delcath Systems, Inc. Announces Preliminary Revenue Results for the Third Quarter of 2024 - Marketscreener.com
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results - StockTitan
Bullish Delcath Systems Insiders Rewarded As Their Investment Rises To US$1.94m - Simply Wall St
When the Price of (DCTH) Talks, People Listen - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Intrahepatic Cholangiocarcinoma Market Report 2034 | - openPR
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Delcath Systems Inc 주식 (DCTH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Aharon Gil | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,069,710 |
| SALAMON STEVEN A J | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,121,025 |
| Vukovic Vojo | Chief Medical Officer |
Dec 12 '23 |
Buy |
3.00 |
40,000 |
120,000 |
100,000 |
| MICHEL GERARD J | Chief Executive Officer |
Dec 08 '23 |
Buy |
2.94 |
34,000 |
99,960 |
262,345 |
1.38%
0.43%
자본화:
|
볼륨(24시간):